Schond Greenway - Mar 14, 2023 Form 4/A - Amendment Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role: Chief Financial Officer
Signature: /s/ Robert Barrow, Attorney-in-Fact
Stock symbol: MNMD
Transactions as of: Mar 14, 2023
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 4/24/2023, 07:34 PM
Date Of Original Report: Mar 17, 2023
Previous filing: May 23, 2022
Next filing: Jun 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MNMD	Common Shares	Award	$0	+175K	+206.69%	$0.00	260K	Mar 14, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 14, 2023, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date.

Remarks:

Explanatory Note: This Amendment on Form 4/A is being filed to amend the Form 4 filed on March 17, 2023, solely to adjust the number of securities included in Table I under "Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)" to give effect for the 15-for-1 reverse share split the Company effected on August 26, 2022.